Remond J.A. Fijneman
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 36
- Cancer, Lipids, and Metabolism 10
- Oncology top 2%
- Colorectal Cancer Treatments and Studies 26
- Colorectal Cancer Screening and Detection 15
- Colorectal Cancer Surgical Treatments 10
-
- Genetic factors in colorectal cancer 48
- Immunology top 5%
- Molecular Biology top 5%
- RNA modifications and cancer 11
-
- Advanced Proteomics Techniques and Applications 8
- Co-authors
- Gerrit A. MeijerPeter DémantBeatriz CarvalhoConnie R. JiménezPien M. Delis‐van DiemenMeike de WitRitsert C. JansenJeroen A.M. Beliën
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (2 papers)Nature Genetics (1 paper)
- Partner nations
- NetherlandsUnited StatesSpain
In The Last Decade
Remond J.A. Fijneman
125 papers receiving 4.0k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 1.2k
- Oncology 1.3k
- Pathology and Forensic Medicine 699
- Immunology 619
- Molecular Biology 2.0k
Countries citing papers authored by Remond J.A. Fijneman
This map shows the geographic impact of Remond J.A. Fijneman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remond J.A. Fijneman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remond J.A. Fijneman more than expected).
Fields of papers citing papers by Remond J.A. Fijneman
This network shows the impact of papers produced by Remond J.A. Fijneman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remond J.A. Fijneman. The network helps show where Remond J.A. Fijneman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Remond J.A. Fijneman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 11 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 4 | |
| 6 | 2023 | 6 | |
| 7 | 2023 | 9 | |
| 8 | 2022 | 22 | |
| 9 | 2022 | 18 | |
| 10 | 2022 | 21 | |
| 11 | 2022 | 9 | |
| 12 | 2021 | 14 | |
| 13 | 2021 | 3 | |
| 14 | 2021 | 26 | |
| 15 | 2018 | 12 | |
| 16 | 2018 | 42 | |
| 17 | 2016 | 137 | |
| 18 | 2012 | 42 | |
| 19 | 2011 | 108 | |
| 20 | High Frequency of Interactions between Lung Cancer Susceptibility Genes in the Mouse: Mapping of Sluc5 to Sluc14 | 1998 | 5 |
About Remond J.A. Fijneman
Remond J.A. Fijneman is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 130 papers that have together received 4.1k indexed citations. Recurring topics across this work include Genetic factors in colorectal cancer (48 papers), Cancer Genomics and Diagnostics (36 papers), Colorectal Cancer Treatments and Studies (26 papers), Colorectal Cancer Screening and Detection (15 papers), RNA modifications and cancer (11 papers), Colorectal Cancer Surgical Treatments (10 papers), Cancer, Lipids, and Metabolism (10 papers) and Advanced Proteomics Techniques and Applications (8 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (1.3k citations) and Pathology and Forensic Medicine (699 citations). Remond J.A. Fijneman has collaborated with scholars based in Netherlands, United States and Spain. Frequent co-authors include Gerrit A. Meijer, Peter Démant, Beatriz Carvalho, Connie R. Jiménez, Pien M. Delis‐van Diemen, Meike de Wit, Ritsert C. Jansen, Jeroen A.M. Beliën, Sandra S. de Vries and Mark A. van de Wiel. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.